1. Home
  2. PAX vs SYRE Comparison

PAX vs SYRE Comparison

Compare PAX & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Patria Investments Limited

PAX

Patria Investments Limited

HOLD

Current Price

$11.95

Market Cap

2.2B

Sector

Finance

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$40.14

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PAX
SYRE
Founded
1988
2013
Country
Cayman Islands
United States
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.2B
2.6B
IPO Year
2020
2015

Fundamental Metrics

Financial Performance
Metric
PAX
SYRE
Price
$11.95
$40.14
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
1
7
Target Price
$20.00
$55.57
AVG Volume (30 Days)
998.6K
709.5K
Earning Date
01-01-0001
05-19-2026
Dividend Yield
4.87%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$13.00
N/A
Revenue Next Year
$15.87
N/A
P/E Ratio
$25.65
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.44
$10.91
52 Week High
$17.80
$45.76

Technical Indicators

Market Signals
Indicator
PAX
SYRE
Relative Strength Index (RSI) 20.89 56.66
Support Level $10.12 $14.62
Resistance Level $14.53 $45.76
Average True Range (ATR) 0.48 2.35
MACD -0.09 -0.24
Stochastic Oscillator 6.44 47.96

Price Performance

Historical Comparison
PAX
SYRE

About PAX Patria Investments Limited

Patria Investments Ltd is an alternative asset management firm specializing in resilient sectors across select regions. It seeks to provide world-wide and Latin American investors with attractive investment products that allows portfolio diversification and consistent returns. The group promotes inclusive and sustainable development in the Asset Classes: Private Equity, Private Equity Solutions, Credit, Real Estate, Infrastructure, and Public Equities Main sectors: Agribusiness, Power & Energy, Healthcare, Logistics & Transportations, Food & Beverage and Digital & Tech Services Investment Regions.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: